Ravi Kiron, Ph.D.
Dr. Kiron is an experienced pharma/biotech executive with decades of experience from early drug discovery through late-stage clinical development, intellectual property, regulatory strategy and product commercialization. He currently serves as Head of BioPharma External Innovation at EMD Serono, the biopharmaceutical division of Merck KGaA. Dr. Kiron has consulted for dozens of life sciences companies, founded and led multiple new ventures, was an EIR at SRI Ventures, and serves currently on many company and non-profit boards. Dr. Kiron has also held operational & executive roles at Pfizer and J&J/Alza in cardiovascular and oncology R&D and strategic business development. He has a wide breadth of hands-on experience negotiating and executing partnerships, mergers and acquisitions, and has extensive global networks. Previously, he was a faculty member at Cornell University Medical College and at University of Rhode Island. Dr. Kiron earned BS and MS degrees from the University of Mumbai, a PhD from the Indian Institute of Science, and an MBA from Rensselaer Polytechnic Institute.